Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population

Overview

About this study

We will evaluate the end to end remote monitoring system in a less controlled environment and concurrently develop the infrastructure to support the back end of the system

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Outpatients
Stable NYHA Class I-III HF (defined as no admissions for > 1 year)
Recruited from the Mayo Heart Failure Clinic, including 15 men and 15 women
Age > 50 years
Reside in Olmsted County

Exclusion Criteria:

Hospital admission for HF within past year
Dementia
Overall life expectancy < 1 year
Blindness
Pregnancy or women able to become pregnant
Skin allergy to adhesives
Inadequate cell phone coverage (international patients or international travel during study period)
Documented EF of >40%

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Lyle Olson, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Lyle Olson, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials